GRC
富华资本
The bundle does not contain material specifically about a fund or entity named "GRC." The relations labeled – that attach "GRC" to PAM2L Biotechnologies are drawn from 5Y Capital and Yunqi Capital announcements about that deal, but these snippets do not define what "GRC" stands for or describe it as an organization.
The document chunks retrieved (–) are all about **Oasis Capital (绿洲资本)**, a Chinese early- and growth-stage VC focused on robotics, AI, and tech-enabled services, with check sizes of $3–30 million. These chunks are tagged with low cosine similarity (0.45) and appear to be background matches rather than material about a subject named "GRC."
elsewhere's corpus does not cover this subject.
AI-generated — may contain errors, please verify.
Coverage
February: Returning to Our Imagination of the World | 5Y News Monthly
The big news from last month.
5Y News | Portfolio Company PAM2L Biotechnologies Closes Pre-A Round of Over 100 Million RMB
Leveraging synthetic biology and machine learning as dual engines to drive bio-based materials and product development.
"Bioyen Bio" Closes Over 100 Million Yuan Pre-A Round, Led by Yunqi Capital | Yunqi Capital
Leading research in materials synthetic biology, building an efficient innovation R&D platform
